Australia joins Indonesian $15.3 million AIDS project:
This article was originally published in Clinica
Executive Summary
A memorandum of understanding has been signed between Indonesia and Australia for an AIDS prevention and care campaign worth Aus$20.12 million ($15.3 million). The aim is to support the national AIDS commission of Jakarta, and other projects (to include other sexually transmitted diseases) in Bali, East Nusa Tenggara, and South Sulawesi provinces. Estimates suggest that some 2 million Indonesians may be HIV-positive by the year 2000. This would place Indonesia in third place in the world HIV league behind Thailand and India. As of October, there were 346 cases of HIV and AIDS reported in 15 of Indonesia's 27 provinces, though it is suggested that the unofficial count could be 100 to 200 times higher than this.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.